ALVOW
AlvotechHealthcare · $3.5B market cap
Verdict
We can't put a fair value on ALVOW right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Earnings per share growth—?
Equity per share growth—?
Sales growth59.5% a year✓
Free cash flow growth—?
Return on invested capital-11.0%✗
Follow ALVOW
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
1 of the investors we track holds ALVOW. Who we track
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works